Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non-frequently exacerbating COPD patients: The FLASH randomized controlled trial

Peter A. Frith, Samiha Ashmawi, Srikanth Krishnamurthy, Alev Gurgun, Sashka Hristoskova, Virginia Pilipovic, Anna Marie Hamann, Arthur Backer, Petter Olsson, Konstantinos Kostikas, Dina V. Diaz, on behalf of the FLASH Investigators

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non-frequently exacerbating COPD patients: The FLASH randomized controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science